JSPR -
Jasper Therapeutics, Inc. Common Stock
Day |
1m |
10m |
60m |
PreMarket |
Market |
AfterHours |
Gap |
2.4 0.2 (8.33%) |
--- |
--- |
0.0 (0.0%) |
0.05 (2.08%) |
0.1 (4.2%) |
0.06 (2.36%) |
0.06 (2.36%) |
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.
Earnings & Ratios
- Basic EPS:
- -1.41
- Diluted EPS:
- -1.41
- Basic P/E:
- -1.844
- Diluted P/E:
- -1.844
- RSI(14) 1m:
- 100.0
- VWAP:
- 2.6
- RVol:
- 1.0148
Events
Period |
Kind |
Movement |
Occurred At |
1m |
Price increase 1m |
2.59 +0.04 (+1.57%) |
Oct 15 18:09 |
1m |
Price decrease 1m |
2.52 -0.03 (-1.18%) |
Oct 15 10:00 |
1m |
Price decrease 1m |
2.52 -0.04 (-1.56%) |
Oct 15 09:59 |
10m |
Price increase 10m |
2.55 +0.07 (+3.03%) |
Oct 15 09:58 |
1m |
Price decrease 1m |
2.47 -0.03 (-1.2%) |
Oct 15 09:48 |
Related News
JSPR INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Jasper
Oct 12, 2025 13:08
Bragar Eagel & Squire, P.C. Reminds Investors of Jasper, KBR, Spirit Aviation, and Molina to Contact the Firm About their Rights in Filed Class Action Lawsuits
Oct 11, 2025 15:41
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Jasper Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – JSPR
Oct 07, 2025 19:00
ROSEN, A GLOBAL INVESTOR RIGHTS LAW FIRM, Encourages Jasper Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – JSPR
Oct 05, 2025 17:59
JASPER LAWSUIT ALERT: Bragar Eagel & Squire, P.C. Reminds Investors a Jasper Investors to Contact the Firm Regarding Class Action Lawsuit
Oct 04, 2025 15:03
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Jasper Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – JSPR
Oct 01, 2025 18:55
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Jasper Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – JSPR
Sep 25, 2025 22:11
Pomerantz Law Firm Announces the Filing of a Class Action Against Jasper Therapeutics, Inc. and Certain Officers – JSPR
Sep 24, 2025 14:45
Pomerantz Law Firm Announces the Filing of a Class Action Against Jasper Therapeutics, Inc. and Certain Officers – JSPR
Sep 24, 2025 05:00
JASPER ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Jasper Therapeutics, Inc. and Encourages Investors to Contact the Firm
Sep 23, 2025 21:13